Necrobiotic xanthogranuloma

Area of Science:

• Dermatology
• Pathology
• Hematology

Background:

• Necrobiotic xanthogranuloma (NXG) is a rare, destructive xanthogranuloma affecting dermal and subcutaneous tissues.
• NXG commonly presents on the face, particularly the periorbital region, and trunk.
• Associated conditions include monoclonal gammopathy (frequently IgG-kappa), cryoglobulinemia, anemia, and leukopenia.

Purpose of the Study:

• To review cases of necrobiotic xanthogranuloma.
• To describe the clinical presentation, systemic involvement, and treatment outcomes for NXG.

Main Methods:

• Retrospective review of 32 patient cases.
• Inclusion of 16 cases from existing world literature.
• Analysis of clinical course, laboratory findings, and treatment responses.

Main Results:

• NXG is characterized by destructive dermal and subcutaneous lesions, primarily affecting the face and trunk.
• Common laboratory findings include monoclonal gammopathy (IgG-kappa/lambda), cryoglobulins, low complement, anemia, and leukopenia.
• Bone marrow examination may reveal plasma cell proliferation or myeloma. Systemic involvement, including myocardial lesions, was observed.

Conclusions:

• Necrobiotic xanthogranuloma is a chronic, progressive condition with potential systemic manifestations.
• Low-dose chlorambucil is a safe and effective treatment option.
• Alternative treatments include corticosteroids, melphalan, radiation, and plasma exchange.